Loading current stock analysis…
Loading current stock analysis…
India
As of 18 Sept 2026, 03:30 pm
JM Financial's Rajiv Berlia noted that Indian IT margins were supported by rupee depreciation in the current fiscal year, but FY28 could see pressure if this support fades. He anticipates earnings estimates may be cut in the latter half of FY27 due to increasing competition. Despite these potential headwinds, Berlia maintains buy or add ratings on nine out of fifteen covered stocks, with Mphasis and Sagility being preferred picks.
At the AGM held on August 20, 2026, Sagility Limited's shareholders approved the adoption of audited financial statements for the fiscal year ending March 31, 2026. They also re-appointed Mr. Hari Gopalakrishnan as a Non-Executive, Non-Independent Director. Additionally, an interim dividend of ₹0.05 per share was confirmed, and a final dividend of ₹0.10 per share was declared for the same fiscal year.
As of September 17, 2026, Sagility's stock has shown mixed returns across different periods, with a 6-month return of 18% and a 3-month return of 13%, but a year-to-date return of -14%. Technically, the daily trend shows a bullish Supertrend indicator at 43.12, with the closing price at ₹44.56. However, the weekly trend indicates a bearish Supertrend at 48.85, and the monthly trend also shows a bearish Supertrend at 60.6.
Sagility Limited is scheduled to participate in the 2026 Jefferies India Forum on September 18, 2026, in Gurgaon. Company officials will hold in-person meetings with investors for general discussions. Additionally, the company has informed the exchange about a schedule of other analyst and institutional investor meetings.
As of 18 Sept 2026, 03:30 pm
Showing 3 of 14 candles
Recent drawdown or price variability is high enough to warrant closer monitoring.
Primary driver: Price remains materially below a previous peak
The session opened materially above the previous close, indicating a sharp repricing at the open.
The move may reflect new information; subsequent price follow-through is worth monitoring.
The session opened materially below the previous close, indicating a sharp repricing at the open.
The price gap may increase short-term downside uncertainty and warrants review of the underlying context.
Upward price movement of 3.14 standard deviations recorded on 2026-08-28.
Unusual market activity that may warrant review of the underlying price, volume, or news context.
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Revenue From Operations | ₹1,963.48 crore | PEAK₹2,024.26 crore | ₹1,971.15 crore | ₹1,658.50 crore | ₹1,538.94 crore |
| Profit Loss For Period | ₹216.81 crore | ₹257.73 crore | PEAK₹267.66 crore | ₹250.83 crore | ₹148.56 crore |
| Profit Before Tax | ₹287.48 crore | PEAK₹363.18 crore | ₹338.52 crore | ₹326.81 crore | ₹210.39 crore |
| Profit Before Exceptional Items And Tax | ₹302.57 crore | ₹363.18 crore | PEAK₹371.34 crore | ₹326.81 crore | ₹210.39 crore |
| Finance Costs | ₹21.89 crore | ₹22.10 crore | ₹24.66 crore | ₹24.99 crore | PEAK₹27.41 crore |
| Other Expenses | PEAK₹297.73 crore | ₹262.71 crore | ₹240.89 crore | ₹216.34 crore | ₹205.64 crore |
Revenue from operations was ₹1,963.48 crore in the June quarter, compared with ₹2,024.26 crore in the March quarter, a decline of ₹60.77 crore, or 3.0%. This follows a series of quarterly increases: revenue had risen from ₹1,538.94 crore in Q1 FY2025‑26 to ₹2,024.26 crore in Q4 FY2025‑26. Despite the sequential dip, revenue was ₹424.54 crore higher than the same quarter a year ago, reflecting a 27.6% year‑on‑year gain.
EBITDA margin, calculated as (profit before exceptional items and tax plus depreciation and finance costs) divided by revenue from operations, stood at 23.0%. Net profit margin was 11.0%.
The debt‑equity ratio was 0.0011, unchanged from the previous quarter and down from 0.0015 a year earlier. Finance costs fell to ₹21.89 crore, a 20.1% year‑on‑year decline and a marginal 0.9% sequential drop. Interest coverage, computed as (profit before tax plus finance costs) divided by finance costs, was 14.13, indicating that operating profit comfortably covered interest expense.
Sagility’s Q1 revenue declined sequentially after a period of consistent growth, while year‑on‑year revenue increased by 27.6%. Profit dipped more steeply as other expenses rose and exceptional charges reappeared. The company maintains a negligible debt load, and finance costs are declining.
Exchange disclosures and regulatory announcements for Sagility.
SAGILITY LIMITED has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Sagility Limited will participate in the 2026 Jefferies India Forum on September 18, 2026, at The Oberoi, Gurgaon, starting at 10:00 AM. Company officials will hold in-person meetings with multiple investors for general discussion.
At the 5th Annual General Meeting held on August 20, 2026, shareholders of Sagility Limited re-appointed Mr. Hari Gopalakrishnan (DIN: 03289463) as a Non-Executive Non-Independent Director, who was retiring by rotation and eligible under Section 152(6) of the Companies Act, 2013. Mr. Gopalakrishnan is a partner and global co-head of services at BPEA EQT and has over 16 years of experience.
Sagility Limited's 5th Annual General Meeting held on August 20, 2026, resulted in the approval of three resolutions: adoption of audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026; re-appointment of Mr. Hari Gopalakrishnan as a Non-Executive, Non-Independent Director; and confirmation of an interim dividend of Rs. 0.05 per share alongside a declaration of a final dividend of Rs. 0.10 per share for the same fiscal year. The voting process was scrutinized by Chandrasekaran Associates, with remote e-voting conducted between August 17 and 19, 2026, and all resolutions passed with requisite majorities.
On August 20, 2026, Sagility Limited re-appointed Mr. Hari Gopalakrishnan as a Non-Executive Non-Independent Director pursuant to retirement by rotation under the Companies Act, 2013. The filing indicates a term of appointment of zero months, signifying that no fixed tenure applies to this re-appointment.
Sagility Limited held its 5th Annual General Meeting on August 20, 2026 at 4:00 p.m. IST via video conference. Shareholders transacted ordinary business including the adoption of audited financial statements for the year ended March 31, 2026, the re-appointment of director Hari Gopalakrishnan, and confirmation of an interim dividend of Rs. 0.05 per share plus a final dividend of Rs. 0.10 per equity share for fiscal 2026. The meeting concluded at 5:07 p.m. IST.
Sagility Limited has announced its participation in the Emkay Confluence 2026 conference, scheduled for August 13, 2026, at 10:00 AM at the Grand Hyatt in Mumbai. Company officials will attend the event to engage in general discussions with analysts and institutional investors through group and one-to-one sessions. The meeting is conducted in-person, with Abhishek Kayan designated as the contact person for investor services.
Sagility Limited informed stock exchanges on August 10, 2026, that its officials will attend the Emkay Confluence 2026 investor conference in Mumbai on August 13, 2026, for group and one-on-one meetings, where only publicly available information will be discussed.
Recent market and company developments associated with Sagility.
JM Financial's Rajiv Berlia says Indian IT margins held up this year mainly because of rupee depreciation, and FY28 could see pressure return if that support fades. He expects earnings estimates to be cut to neutral in the second half of FY27 as competition rises. He still holds buy or add ratings on nine of his 15 covered stocks, led by Mphasis and Sagility.
The global private-equity firm plans to expand beyond large buyouts into data centres, infrastructure, mid-market companies, venture capital and secondary transactions in India.
IT firms, Infosys, HCL Tech, Coforge, Tech Mahindra, Wipro stock , Wipro, Persistent Systems, Tata Elxsi, Tata Consultancy Services Ltd , Zensar Technologies, IT stocks, IT stocks fall, Nifty IT index, BSE IT index, Indian stock market, artificial intelligence
Sagility Group CEO Ramesh Gopalan reaffirms low double-digit organic growth guidance for FY27, citing strong Q3 visibility despite an unclear Q4. He details how the company shares 70-80% of AI-driven efficiency gains with clients while expanding the scope of work it handles, and addresses questions on PE ownership and the recent Careseed acquisition.
Stocks to buy for the short term: Experts highlight six stocks to buy for short-term gains, backed by robust technical indicators and market momentum. Dive into the analysis to learn more.
Trade Spotlight
Phoenix Mills Ltd saw volume of 1.28 lakh shares by 10:45 IST on BSE, a 16.81 fold spurt over two-week average daily volume of 7623 shares
Bajaj Broking’s Pabitro Mukherjee believes the broader market structure has turned constructive, with dips likely to attract buying interest. He recommends four top stock picks, hinting at a bullish reversal.
Comprehensive Section Breakdown for Sagility
Strategic Vision: Transformation partner for healthcare operations using technology.
Category: B2B Services
Sagility provides business process management services employing AI, intelligent automation, and deep domain expertise to assist clients in reducing administrative costs, automating workflows, and optimizing performance.
Key Products & Services: CareSeed • SmarTec Nurse Assist
• Integration of AI, intelligent automation, and deep domain expertise in healthcare operations.
• Focus on simplifying healthcare processes and enhancing operational performance for payers and providers.
Sagility Limited reported revenue of ₹1,963.48 crore for the quarter ended 30 June 2026, a 3% decline from the previous quarter, while year-on-year growth remained strong at 27.6%. Net profit fell 15.9% sequentially to ₹216.81 crore, a sharper drop than revenue, as other expenses rose and exceptional items reappeared. The company’s balance sheet carries minimal debt, and finance costs continued to fall.
Profit before tax (PBT) fell 20.8% sequentially to ₹287.48 crore from ₹363.18 crore in the March quarter. Compared with ₹210.39 crore in the year‑earlier quarter, PBT was 36.6% higher. Net profit for the period was ₹216.81 crore, down 15.9% quarter‑on‑quarter and up 45.9% year‑on‑year.
The steeper drop in profit was driven by two factors. Other expenses rose to ₹297.73 crore, a 13.3% increase from the previous quarter and a 44.8% jump from the year‑ago period. This growth in other expenses outpaced the 27.6% year‑on‑year revenue increase, signalling cost pressure. Employee benefit expense was ₹1,227.59 crore, representing 62.5% of revenue.
The company also recorded exceptional items of ₹15.09 crore in the quarter (an expense that reduced PBT). Profit before exceptional items and tax was ₹302.57 crore, compared with ₹363.18 crore in the March quarter, which had no exceptional items.
Core Thesis: The business units reinforce each other by combining advanced technology with deep-domain expertise to deliver tailored solutions and act as a transformation partner.
• Intelligent Technologies: Leveraging AI and intelligent automation to simplify healthcare processes and enhance operational performance. • Human-Centered Operations: Employing human expertise alongside technology to deliver tailored solutions for healthcare payers and providers. • Domain Expertise: Utilizing deep knowledge of healthcare operations to assist clients in improving specific performance metrics and driving revenue.